Solving Major Bottlenecks in Genetic Medicine & SynBio w DNA Synthesis Innovation


APR 15, 2024

In this episode of Big4Bio's Company to Watch, Danny Levine interviews Matthew Hill, Ph.D., founder and CEO of Elegen, on the next big innovation in manufacturing DNA, which bypasses synthetic DNA bottlenecks to accelerate upstream and downstream workflows.